Efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients after acute myocardial infarction - ESTEEM

Description:

The goal of the ESTEEM trial was to evaluate the safety and efficacy of treatment with the novel oral direct thrombin inhibitor ximelagatran in patients following ST or non-ST elevation myocardial infarction (MI).